Stryker launches Restep deep vein thrombosis compression sleeve


Stryker’s Sustainability Solutions division has announced the launch of Restep, a compression sleeve for deep vein thrombosis treatment. 

Restep provides hospitals with a single-source opportunity for deep vein thrombosis compression sleeves and allows hospitals an opportunity to lower costs by minimising their number of suppliers.

According to a company release, Restep addresses a critical need in the market for comprehensive device solutions that deliver fiscal and environmental value to hospitals by integrating original manufactured and reprocessed medical devices.

“Restep marks the first time we can tangibly demonstrate what the integration of reprocessing into the original equipment manufacturer business model means for the industry. By creating a medical device solution that integrates original manufactured and reprocessed devices, we have introduced a new precedent in how technology suppliers can offer value to hospitals,” said Lars Thording, Stryker Sustainability Solutions’ senior director of marketing and public affairs. “Value lies in true sustainability―environmental and financial sustainability. With Restep, hospitals will be able to opt for less environmentally impactful products without sacrificing quality or financial prudence.”

“To our hospital, Restep will bring better value all around. We expect patients to be more comfortable and our supply chain managers will not only see the convenience and efficiency, but also reduced environmental impact,” said Tony Benedict, Abrazo Healthcare’s vice president of supply chain. “The launch of Restep not only elevates Stryker Sustainability Solutions’ role as a key supplier to our hospital, but sets the bar for other suppliers, as well.”